Practical Implications of No IGF-1 Elevation: The absence of IGF-1 stimulation makes AOD-9604 suitable for populations who need to avoid IGF-1 elevation, including individuals with personal or family history of hormone-sensitive cancers, those concerned about accelerated aging through growth pathway activation, people seeking fat loss without anabolic muscle-building effects, individuals who have contraindications to growth hormone therapy, and those undergoing screening or monitoring where IGF-1 elevation would be problematic
There is also observational evidence that GLP-1 RAs may protect against obesity-associated cancers (165)
Mechanism: BPC-157 modulates the inflammatory response, helping to decrease swelling and pain
Oral (Capsule): For gastrointestinal studies, oral administration is preferred
The result is a brighter, more even complexion with a natural glow
Evidence grade: solid for topical skin benefit